About the Authors
- Martin Neumann
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Ebru Coskun
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Lars Fransecky
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Liliana H. Mochmann
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Isabelle Bartram
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Nasrin Farhadi Sartangi
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Sandra Heesch
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Nicola Gökbuget
-
Affiliation Goethe University Hospital, Department of Medicine II, Hematology and Oncology, Frankfurt/Main, Germany
- Stefan Schwartz
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Christian Brandts
-
Affiliation Goethe University Hospital, Department of Medicine II, Hematology and Oncology, Frankfurt/Main, Germany
- Cornelia Schlee
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Rainer Haas
-
Affiliation Department of Hematology and Oncology, University of Düsseldorf, Düsseldorf, Germany
- Ulrich Dührsen
-
Affiliation Department of Hematology and Oncology, University of Essen, Essen, Germany
- Martin Griesshammer
-
Affiliation Department of Hematology and Oncology, Klinikum Minden, Minden, Germany
- Hartmut Döhner
-
Affiliation Department of Internal Medicine III, University of Ulm, Ulm, Germany
- Gerhard Ehninger
-
Affiliation Department of Hematology and Oncology, University of Dresden, Dresden, Germany
- Thomas Burmeister
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Olga Blau
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Eckhard Thiel
-
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
- Dieter Hoelzer
-
Affiliation Goethe University Hospital, Department of Medicine II, Hematology and Oncology, Frankfurt/Main, Germany
- Wolf-Karsten Hofmann
-
Affiliation University Hospital Mannheim, Department of Hematology and Oncology, Mannheim, Germany
- Claudia D. Baldus
-
* E-mail: claudia.baldus@charite.de
Affiliation Charité, University Hospital Berlin, Campus Benjamin Franklin, Department of Hematology and Oncology, Berlin, Germany
Competing Interests
TKI258 was a kind gift from Novartis (Basel, Switzerland). There are no further patents, products in development or marketed products to declare. This does not alter the authors‚ adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: MN NG DH ET CDB. Performed the experiments: MN EC LF LM IB NFS SH SS CS OB. Analyzed the data: MN EC TB CDB. Contributed reagents/materials/analysis tools: CB RH UD MG HD GE. Wrote the paper: MN EC SS WKH CDB.